Detalles de la búsqueda
1.
Knockdown of YAP/TAZ sensitizes tamoxifen-resistant MCF7 breast cancer cells.
Biochem Biophys Res Commun
; 601: 73-78, 2022 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35231654
2.
Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type.
Breast Cancer Res Treat
; 184(2): 527-542, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32794061
3.
Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society.
Breast Cancer Res Treat
; 173(3): 679-691, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30390214
4.
Targeting HIF-1α is a prerequisite for cell sensitivity to dichloroacetate (DCA) and metformin.
Biochem Biophys Res Commun
; 469(2): 164-70, 2016 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26616058
5.
Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer.
Breast Cancer Res Treat
; 150(1): 141-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25682076
6.
Primary apocrine sweat gland carcinomas of the axilla: a report of two cases and a review of the literature.
World J Surg Oncol
; 13: 59, 2015 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25888740
7.
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
Expert Opin Biol Ther
; 24(4): 305-312, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38664937
8.
Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?
Ann Surg Treat Res
; 105(1): 31-36, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441320
9.
Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors.
Anticancer Res
; 43(5): 1973-1980, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097659
10.
Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy.
Ann Surg Treat Res
; 105(1): 1-9, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441319
11.
Survival benefit from axillary surgery in patients aged 70 years or older with clinically node-negative breast cancer: A population-based propensity-score matched analysis.
Eur J Surg Oncol
; 48(12): 2385-2392, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35922281
12.
The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer.
J Breast Cancer
; 25(5): 387-403, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36314765
13.
The Prediction of HER2-Targeted Treatment Response Using 64Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report.
J Breast Cancer
; 25(1): 69-73, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35133094
14.
Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society Registry.
Ann Surg Treat Res
; 103(6): 313-322, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36601341
15.
miR-3188 Enhances Sensitivity of Breast Cancer Cells to Ionizing Radiation by Down-regulating Rictor.
Anticancer Res
; 41(12): 6169-6176, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34848471
16.
A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer.
EJNMMI Res
; 11(1): 8, 2021 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33475899
17.
Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1.
Sci Rep
; 10(1): 641, 2020 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959810
18.
Hypoxia Suppresses Cysteine Deprivation-induced Cell Death Via ATF4 Regulation in MDA-MB-231 Breast Cancer Cells.
Anticancer Res
; 40(3): 1387-1394, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32132035
19.
Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status.
J Breast Cancer
; 23(1): 10-19, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32140266
20.
Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning.
Sci Rep
; 10(1): 21149, 2020 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33273490